• OPEN AN ACCOUNT
Indian Indices
Nifty
24,666.90 88.55
(0.36%)
Sensex
81,330.56 182.34
( 0.22%)
Bank Nifty
54,801.30 -139.55
( -0.25%)
Nifty IT
37,853.55 498.95
( 1.34%)
Global Indices
Nasdaq
42,160.14 -270.96
(-0.64%)
Dow Jones
5,907.19 42.00
(0.72%)
Hang Seng
38,121.59 -61.67
(-0.16%)
Nikkei 225
8,585.01 -17.91
(-0.21%)
Forex
USD-INR
84.87 -0.55
(-0.64%)
EUR-INR
94.53 -1.49
(-1.55%)
GBP-INR
112.13 -1.43
(-1.26%)
JPY-INR
0.58 -0.01
(-2.04%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
139.278683
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
69.74
1171.95
EPS(TTM)
Face Value()
Div & Yield %
28.52
10
0
 

narbada gems & jewellery ltd
Terraform Magnum Ltd - Board Meeting Outcome for Intimation Of The Outcome Of Board Meeting And Disclosure Under SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Dec 05,2024
Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you on the Recommendation of Nomination and Remuneration Committee that the Board of Directors of Terraform Magnum Limited (the Company) at its Meeting held today i.e. December 05 2024 at 3.00 p.m. and concluded at 3:30 p.m have inter-alia considered and approved the appointment of Ms. Surabhi Shewaramani (A73243) as Company Secretary & Compliance Officer of the Company with effect from 05rd December 2024.